Bone marrow cells from adult patients with acute leukemia were serially cultured using an in vitro agar culture method. Four categories of growth pattern were recognized according to growth characteristics in vitro in previously untreated patients with leukemia. Detailed cytological investigation was performed for the determination of cell morphology and the origin of colonies. In vitro agar culture may be useful for monitoring the remission-relapse status in acute leukemia. --acute leukemia; hemopoietic stem cell; chemotherapy
The development of bone marrow culture technics in vitro has permitted detailed analysis of colony forming cells (CFC) in the marrow of acute leukemia patients. It has been repeatedly shown that bone marrow cells from patients with acute nonlymphoblastic leukemia (ANLL) reveal defective colony formation in soft agar culture in vitro.
The present study was carried out to investgate in vitro colony forming ability in patients with acute leukemia and changes of CFU-c (colony forming units in culture) during RCMP (daunorubicin, cytosine-arabinoside, 6-mercaptopurine and prednisolone) two step therapy, to evaluate the prognostic utility of the in vitro assay for CFU-c (Uzuka et al. 1976; Uzuka 1980).
MATERIALS AND METHODS
Patients. Three adult patients with acute lymphoblastic leukemia (ALL), 25 with ANLL and 1 with erythroleukemia admitted to our hospital between July 1977 and January 1979 were subjected to this study (Table 1) .
Therapy. Most patients were treated with DCMP two step therapy and some with COAP (cyclophosphamide, oncovine, Ara-C and prednisolone) and VP (vincristine and prednisolone) protocol for remission induction. Complete remission was defined according to the criteria of the Midwest Co-perative Study Group (Hewlett et al. 1964 ). After achieving complete remission, the patients received 2 to 4 additional courses of consolidation therapy at 2 to 3 weeks intervals, usually with the same agents as used for remission induction. Following the remission consolidation therapy, the patients received remission maintenance therapy at approximately monthly intervals until relapse or the completion of 3 years of treatment.
Assay for CFU-c. The culture was performed according to a modification of the Pike and Robinson method (Pike and Robinson 1970) . Heparinized bone marrow samples were allowed to sediment at room temperature for about 1 hr before removal of cell rich supernatant. Following three washes with modified Mccoys'5A medium, the cells were resuspended in the medium containing 15% fetal calf serum (FCS) and 0.3% Seaplaque agarose (final concentration of 2>< 105 cells/ml), and 1 ml aliquots were laid on the top of previously prepared leukocyte underlayers (1 X 106 leukocytes per ml dish in 0.5% agar) in 35 mm plastic petri dishes. The cultures were incubated at 37°C in a humidified atomosphere of 5% CO2 in air and scored for clusters and colonies after 7, 10 and 14 days. Cell aggregates were aspirated by fine Pasteur pipettes, smeared on slides and stained with May-Giemsa staining and cytochemical stainings for the examination of cell morphology. A colony was defined as an aggregate of more than 50 cells. An aggregation of 50 cells or less was referred to as a cluster.
RESULTS
The growth patterns of bone marrow cells cultured in vitro from untreated leukemia patients were classified into the following four categories : I) Neither colony nor cluster formation was observed at 7, 10 or 14 days culture. II) Only varying numbers of clusters, but no colonies, were observed at 7 days. When the cultures were scored later than 7 days, the majority of cases showed evidence of colony formation. III) Colony formation with normal or low incidence at 7 days of culture was observed. IV) Numerous colonies were formed at 7 days of culture.
The patients who presented growth pattern I included two each with acute myeloblastic leukemia (AML) and acute monoblastic leukemia (AMoL), and three with ALL. Growth pattern II was observed in one patient each with AML and erythroleukemia. Growth pattern III was found in six with AML, three with acute promyelocytic leukemia and one with AMoL and growth pattern IV in two with AML.
The colonies obtained from some patients consisted of leukemic cells and those from some other patients consisted of normal granulocytic-macrophage progenitor cells. In the patients who showed growth pattern III, the coexistence of normal GM progenitor cells and leukemic cells was demonstrated before treatment. But during chemtherapy normal GM-colonies and leukemic colonies gradually diminished and almost disappeared, while macrophage colonies increased. In the relapsed cases, the incidence of leukemic colonies and macrophage colonies was higher than in untreated cases.
The correlation between clinical outcome and the in vitro growth pattern of bone marrow progenitor cells was investigated in 17 patients with untreated acute leukemia. All six patients who presented growth pattern I and one of the two patients showing growth pattern III attained complete remission. One patient showing growth pattern IV failed to attain complete remission and took a rapid downhill course (Table 1) .
Changes of CFU-c during RCMP two step therapy (Uzuka et al. 1976; Uzuka 1980) were observed in 14 patients with ANLL who attained complete remission.
The growth pattern of marrow cells in vitro from untreated patients with ANLL was characterized by little or no colony formation. After the intensive first step therapy, CFU-c disappeared in all patients subsequent to drug-induced marrow aplasia.
Only one of the 14 patients showed colony formation at the time of initiation or the second step therapy. CFU-c appeared again after the completion of the second step therapy when differential counts of leukemic cells in the marrow decreased to less than 5% (Fig. 1) .
Here, increased frequency of macrophage colonies in the absence of both leukemic colonies and normal granulocytic colonies was noted. Return to the •-., blast cells less than 10%; B, before CP U-c in relapsed patients. The value of bone marrow culture in predicting the onset of relapse was investigated in seven patients in long-term remission.
In the patients who showed evidence of incipient relapse which was confirmed by increased bone marrow blast cell incidence (less than 5%), consistent granulocytopenia and the presence of blast cells in the peripheral blood, a gradual decrease of the number of colonies was observed.
These changes were found 4 to 24 weeks prior to clinical and hematological evidence of overt relapse (Fig. 2) .
DISCUSSION
In agreement with other studies on patients with acute leukemia, variable growth patterns were observed which permit the patients in this study to divide into four subgroups as described above.
Category I is a growth pattern with no normal or leukemic colonies or clusters. Patients in this category had good prognosis, and all of the three patients with ANLL and the three with ALL in this category entered complete remission. Category II comprizes varying numbers of clusters with no or few colony and category III does normal or small numbers of colonies with varying numbers of clusters. Patients in both categories were considered to share a similar prognosis. One of the two patients with ANLL in category II attained complete remission. Four of the eight patients with ANLL in category III attained complete remission. Colony formation seen in both categories was partly due to residual CFU-c. However, the coexistence of leukemic and non-leukemic colonies was also observed.
Category IV comprizes excessive growth of colonies and clusters. Two patients with ANLL in this category both failed to attain complete remission. Our results confirmed those recently reported by others (Metcalf 1975 (Metcalf , 1977 Moore 1976a, b; Spitzer et al. 1976 Spitzer et al. , 1977 , and extended them to more detailed analysis of colony forming cells. The simultaneous presence of normal and leukemic colonies was demonstrated in our study in contrast to those by Spitzer et al. (1978) . When marrow from a patient with acute leukemia in remission is cultured, a growth pattern observed is quite different from that seen in culture of pretreatment marrow. The remission marrow produces a pattern of colony and cluster formation which is identical with a normal marrow culture.
Our results showed that the returning to the normal stem cell growth pattern in marrow culture was associated with eradication of the vast majority of leukemic clones. It is thought that in acute leukemia normal CFU-c are expelled from an active cycle to a resting state and after the eradication of the leukemic clone the growth of normal stem cells is released from inhibition which may be exercized by leukemic cells. Spitzer et al. (1977) demonstrated three growth patterns in vitro clinical outcome. Pattern I is a persistent absence of CFU-c, pattern II an appearance of normal colonies, and pattern III variable numbers of leukemic cluster formation.
After remission induction therapy, most patients were severely pancytopenic and aplastic and marrow culture at this stage showed either of the following three growth patterns. Some of the patients showed persistent absence of CFU-c on repeated bone marrow aspirates and showed no evidence of hematologic recovery or leukemic regrowth and died from infection or hemorrhage. Other patients showed return of CFU-c during the same course of chemotherapy that induced complete remission. Finally, some patients showed persistent leukemic growth in vitro during the initial aplastic marrow and all subsequent cultures, and failed to respond to therapy. Spitzer et al. (1977) noted early return of CFU-c after intensive remission induction therapy. Furthermore, Metcalf (1977) noted that it is fairly common to have leukemic patients under therapy with a relatively aplastic marrow containing 5-20% of abnormal blast cells, and that on culture such marrows can be shown to contain GM-CFCs (granulocytes-macrophages colony forming cells) often in very high frequency and the likelihood in such cases is that remission is actively in progress. He emphasized that assault of this regenerating normal population with an increased level of chemotherapy would be undesirable. From our results, however, colonies did not appear till abnormal blast cells decreased to less than 5% in marrow and the returing to the normal growth pattern in marrow culture was associated with unequivocal complete remission. Therefore additional therapy at this stage is though to be desirable.
Our results confirmed the value of marrow culture in predicting the onset of relapse.
